| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.580 | 18.959 | 12.739 | 63.293 | 19.072 | 5.913 | 558 | 110.047 | 13.141 | 7.325 |
| Total Income - EUR | 17.739 | 19.392 | 12.950 | 63.530 | 19.356 | 6.098 | 680 | 109.771 | 36.656 | 30.967 |
| Total Expenses - EUR | 16.680 | 17.645 | 12.646 | 62.596 | 18.116 | 5.086 | 4.098 | 107.680 | 62.462 | 20.071 |
| Gross Profit/Loss - EUR | 1.059 | 1.747 | 303 | 934 | 1.240 | 1.012 | -3.418 | 2.091 | -25.807 | 10.896 |
| Net Profit/Loss - EUR | 534 | 1.368 | 175 | 286 | 664 | 848 | -3.436 | 1.109 | -25.938 | 9.153 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 1 | 2 | 1 |
Check the financial reports for the company - Nutraceutical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.131 | 1.697 | 1.376 | 951 | 540 | 210 | 0 | 0 | 5.676 | 2.222 |
| Current Assets | 34.578 | 36.024 | 38.825 | 49.293 | 38.413 | 37.238 | 34.207 | 77.544 | 93.750 | 57.470 |
| Inventories | 9.123 | 9.030 | 8.877 | 8.968 | 8.500 | 8.339 | 8.154 | 8.179 | 183 | 182 |
| Receivables | 21.172 | 26.730 | 28.929 | 32.198 | 27.834 | 26.882 | 25.936 | 62.526 | 85.641 | 48.946 |
| Cash | 4.282 | 264 | 1.019 | 8.127 | 2.079 | 2.017 | 117 | 6.838 | 7.925 | 8.342 |
| Shareholders Funds | 10.474 | 11.735 | 11.711 | 11.782 | 12.218 | 12.834 | 9.114 | 10.251 | -15.718 | -19.623 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 26.294 | 25.986 | 28.490 | 38.462 | 26.735 | 24.614 | 25.093 | 37.906 | 54.253 | 42.332 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.387 | 60.891 | 36.982 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Nutraceutical S.r.l.